158 related articles for article (PubMed ID: 30732947)
1. Finding an oral potentially malignant disorder in screening program is related to early diagnosis of oral cavity cancer - Experience from real world evidence.
Ho PS; Wang WC; Huang YT; Yang YH
Oral Oncol; 2019 Feb; 89():107-114. PubMed ID: 30732947
[TBL] [Abstract][Full Text] [Related]
2. Malignant transformation to oral cancer by subtype of oral potentially malignant disorder: A prospective cohort study of Taiwanese nationwide oral cancer screening program.
Chuang SL; Wang CP; Chen MK; Su WW; Su CW; Chen SL; Chiu SY; Fann JC; Yen AM
Oral Oncol; 2018 Dec; 87():58-63. PubMed ID: 30527244
[TBL] [Abstract][Full Text] [Related]
3. Screening for Oral Cavity Cancer: A 1-year Experience of a Regional Hospital in Taiwan.
Chi TH; Yuan CH; Chen RF
JNMA J Nepal Med Assoc; 2014; 52(195):902-6. PubMed ID: 26982664
[TBL] [Abstract][Full Text] [Related]
4. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
5. The influence of marital status on survival for patients aged 65 years and younger with oral cavity cancer.
Liao PH; Lee CC
Auris Nasus Larynx; 2018 Dec; 45(6):1227-1232. PubMed ID: 29685504
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness analysis of the oral cancer screening program in Taiwan.
Huang CC; Lin CN; Chung CH; Hwang JS; Tsai ST; Wang JD
Oral Oncol; 2019 Feb; 89():59-65. PubMed ID: 30732960
[TBL] [Abstract][Full Text] [Related]
7. Risk of Oral and Upper Gastrointestinal Cancers in Persons With Positive Results From a Fecal Immunochemical Test in a Colorectal Cancer Screening Program.
van der Vlugt M; Grobbee EJ; Bossuyt PM; Bos ACRK; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
Clin Gastroenterol Hepatol; 2018 Aug; 16(8):1237-1243.e2. PubMed ID: 29427732
[TBL] [Abstract][Full Text] [Related]
8. Environmental heavy metal as a potential risk factor for the progression of oral potentially malignant disorders in central Taiwan.
Tsai KY; Su CC; Chiang CT; Tseng YT; Lian IB
Cancer Epidemiol; 2017 Apr; 47():118-124. PubMed ID: 28259083
[TBL] [Abstract][Full Text] [Related]
9. Dilemmas of oral cancer screening: an update.
Kujan O; Sloan P
Asian Pac J Cancer Prev; 2013; 14(5):3369-73. PubMed ID: 23803131
[TBL] [Abstract][Full Text] [Related]
10. Regular clinical follow-up of oral potentially malignant disorders results in improved survival for patients who develop oral cancer.
Jäwert F; Nyman J; Olsson E; Adok C; Helmersson M; Öhman J
Oral Oncol; 2021 Oct; 121():105469. PubMed ID: 34371451
[TBL] [Abstract][Full Text] [Related]
11. Effect of esophageal cancer screening on mortality among patients with oral cancer and second primary esophageal cancer in Taiwan.
Chen YH; Ho CM; Wu MS; Hsu WH; Wang WY; Yuan SF; Hsieh HM; Wu IC
Am J Otolaryngol; 2023; 44(4):103856. PubMed ID: 37062150
[TBL] [Abstract][Full Text] [Related]
12. Beneficial impact of multidisciplinary team management on the survival in different stages of oral cavity cancer patients: results of a nationwide cohort study in Taiwan.
Tsai WC; Kung PT; Wang ST; Huang KH; Liu SA
Oral Oncol; 2015 Feb; 51(2):105-11. PubMed ID: 25484134
[TBL] [Abstract][Full Text] [Related]
13. Population-based screening program for reducing oral cancer mortality in 2,334,299 Taiwanese cigarette smokers and/or betel quid chewers.
Chuang SL; Su WW; Chen SL; Yen AM; Wang CP; Fann JC; Chiu SY; Lee YC; Chiu HM; Chang DC; Jou YY; Wu CY; Chen HH; Chen MK; Chiou ST
Cancer; 2017 May; 123(9):1597-1609. PubMed ID: 28055109
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence visualization improves the detection of oral, potentially malignant, disorders in population screening.
Simonato LE; Tomo S; Scarparo Navarro R; Balbin Villaverde AGJ
Photodiagnosis Photodyn Ther; 2019 Sep; 27():74-78. PubMed ID: 31116999
[TBL] [Abstract][Full Text] [Related]
15. Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data Base.
Luryi AL; Chen MM; Mehra S; Roman SA; Sosa JA; Judson BL
JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):593-8. PubMed ID: 25974757
[TBL] [Abstract][Full Text] [Related]
16. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group.
Sankaranarayanan R; Mathew B; Jacob BJ; Thomas G; Somanathan T; Pisani P; Pandey M; Ramadas K; Najeeb K; Abraham E
Cancer; 2000 Feb; 88(3):664-73. PubMed ID: 10649262
[TBL] [Abstract][Full Text] [Related]
17. Leukoplakia, Oral Cavity Cancer Risk, and Cancer Survival in the U.S. Elderly.
Yanik EL; Katki HA; Silverberg MJ; Manos MM; Engels EA; Chaturvedi AK
Cancer Prev Res (Phila); 2015 Sep; 8(9):857-63. PubMed ID: 26159805
[TBL] [Abstract][Full Text] [Related]
18. Screening programmes for the early detection and prevention of oral cancer.
Brocklehurst P; Kujan O; Glenny AM; Oliver R; Sloan P; Ogden G; Shepherd S
Cochrane Database Syst Rev; 2010 Nov; (11):CD004150. PubMed ID: 21069680
[TBL] [Abstract][Full Text] [Related]
19. Impact of oral potentially malignant disorder subtypes on all-cause and cause-specific mortality in males.
Yen AM; Wang ST; Peng BY; Cheng YC; Siewchaisakul P; Hsu CY; Chen SL
Oral Dis; 2019 Apr; 25(3):750-757. PubMed ID: 30592115
[TBL] [Abstract][Full Text] [Related]
20. Countermeasure and opportunistic screening systems for oral cancer.
Morikawa T; Shibahara T; Takano M; Iwamoto M; Takaki T; Kasahara K; Nomura T; Takano N; Katakura A
Oral Oncol; 2021 Jan; 112():105047. PubMed ID: 33129059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
